BARRIE RICHARD FRAGRANCES INC
DEFM14A, 1996-04-22
PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS
Previous: PATRIOT SCIENTIFIC CORP, DEF 14A, 1996-04-22
Next: SCM PORTFOLIO FUND INC, 485BPOS, 1996-04-22




                                  SCHEDULE 14A
                                 (Rule 14a-101)
                     INFORMATION REQUIRED IN PROXY STATEMENT
                            SCHEDULE 14A INFORMATION
                Proxy Statement Pursuant to Section 14(a) of the
                Securities Exchange Act of 1934 (Amendment No. )

 Filed by the  registrant |X|

 Filed by a party other than the registrant|_|
 Check the  appropriate  box:
 | |  Preliminary  proxy  statement
 |X|  Definitive  proxy  statement
 |_|  Definitive  additional  materials
 |_|  Soliciting material pursuant to Rule 14a-11(c) or Rule 14a-12

                         Richard Barrie Fragrances, Inc.
                (Name of Registrant as Specified in Its Charter)

                Peter M. Ziemba, Esq. for Lynn Barrie, Secretary
                   (Name of Person(s) Filing Proxy Statement)

Payment of filing fee (Check the appropriate box):
     |_|      $125 per Exchange Act Rule 0-11(c)(1)(ii), 14a-6(j)(2).

     |_|      $500 per each party to the controversy pursuant to Exchange
                  Act Rule 14a-6(i)(3).

     |X|      Fee computed on table below per Exchange Act Rules 14a-6(i)
              (4)and 0-11.

     (1)      Title of each class of securities to which transaction applies:
              Parlux Fragrances, Inc. common stock, par value $.005 per share
              (the "Parlux Common Stock")

     (2)      Aggregate number of securities to which transactions applies:
              370,000 shares of Parlux Common Stock

     (3)      Per unit price or other underlying value of transaction computed
              pursuant to Exchange Act Rule 0-11:1

                  The  Parlux  Common  Stock  valued at $7.625  per  share,  the
                  average of the high and low sale prices for such shares on the
                  Nasdaq  National Market on February 20, 1996. The Company will
                  also receive $750,000 in cash.

     (4)      Proposed maximum aggregate value of transaction:
              $3,571,250

     (5)      Total Fee Paid:
              $714.25

     |_|      Check  box if any part of the fee is  offset  as  provided  by
              Exchange Act Rule 0-11(a)(2) and identify the filing for which
              the offsetting fee was paid previously.  Identify the previous
              filing  by  registration  statement  number,  or the  form  or
              schedule and the date of its filing.

     (1)      Amount previously paid:


     (2)      Form, schedule or registration statement no.:


     (3)      Filing party:


     (4)      Date filed:

- --------
     1        Set forth the amount on which the filing fee is calculated and
              state how it was determined.


<PAGE>
                             15 Executive Boulevard
                            Orange, Connecticut 06477
                            Telephone: (203) 795-5300



                                    NOTICE OF
                         SPECIAL MEETING OF STOCKHOLDERS


                                  May 31, 1996


                  NOTICE IS HEREBY GIVEN that a Special  Meeting of Stockholders
of Richard Barrie  Fragrances,  Inc. (the "Company") will be held at the offices
of Graubard,  Mollen & Miller,  600 Third Avenue,  New York, New York on Friday,
May 31,  1996,  at 10:00 a.m.,  for the  following  purposes,  all as more fully
described in the attached Proxy Statement:

1.   To approve  the sale by the  Company of  virtually  all of its assets  (the
     "Asset  Sale")  to Parlux  Fragrances,  Inc.  ("Parlux")  in  exchange  for
     $750,000 in cash and 370,000  shares of Parlux  common  stock (the  "Parlux
     Stock");

2.   To approve the subsequent sale of the Parlux Stock;

3.   To amend the Company's  Articles of Incorporation to change the name of the
     Company  immediately after completion of the Asset Sale from Richard Barrie
     Fragrances, Inc. to FBR Capital Corporation;

4.   To elect two directors to take office  immediately after completion of
     the  Asset  Sale  and to  serve  until  the  next  Annual  Meeting  of
     Stockholders of the Company and until their respective  successors are
     elected and  qualified;  and 5. To transact such other business as may
     properly come before the meeting and any and all adjournments thereof.

                  The Board of  Directors  has fixed  the close of  business  on
April  18,  1996,  as the  record  date for the  determination  of  stockholders
entitled to notice of, and to vote at, the meeting or any adjournment thereof.

                  You are  earnestly  requested  to date,  sign and  return  the
accompanying  form of proxy in the envelope  enclosed for that purpose (to which
no postage  need be affixed if mailed in the United  States)  whether or not you
expect to attend the  meeting in person.  The proxy is  revocable  by you at any
time prior to its  exercise  and will not affect your right to vote in person in
the event you attend the meeting or any adjournment  thereof.  The prompt return
of the  proxy  will be of  assistance  in  preparing  for the  meeting  and your
cooperation in this respect will be appreciated.


                                          By Order of the Board of Directors


                                          Lynn Barrie, Secretary
Orange, Connecticut
April 22, 1996


<PAGE>



                         RICHARD BARRIE FRAGRANCES, INC.



                                 PROXY STATEMENT



                         SPECIAL MEETING OF STOCKHOLDERS
                           TO BE HELD ON MAY 31, 1996



                  This Proxy  Statement is furnished to  stockholders of Richard
Barrie  Fragrances,  Inc. (the "Company") in connection with the solicitation of
proxies,  in the accompanying  form, by the Board of Directors for use in voting
at the Special  Meeting of  Stockholders  to be held at the offices of Graubard,
Mollen & Miller,  600 Third Avenue,  New York, New York on Friday, May 31, 1996,
at 10:00 a.m., and at any and all adjournments thereof. Any proxy given pursuant
to this  solicitation may be revoked by the person giving it by giving notice to
the  Secretary  of the Company in person,  or by written  notification  actually
received  by the  Secretary,  at any time prior to its being  exercised.  Unless
otherwise  specified in the proxy,  shares  represented by proxies will be voted
(i) for the approval of the sale of virtually all of the  Company's  assets (the
"Asset Sale") to Parlux Fragrances,  Inc.  ("Parlux"),  (ii) for the approval of
the subsequent sale of the shares of Parlux common stock received as part of the
consideration  in the Asset  Sale,  (iii)  for the  amendment  to the  Company's
Articles  of  Incorporation  to  change  the  Company's  name,  and (iv) for the
election of the nominees for director listed herein.

                  The  Company's  executive  offices are located at 15 Executive
Boulevard,  Orange,  Connecticut  06477.  On or about April 22, 1996, this Proxy
Statement and the accompanying form of proxy, together with a copy of the Annual
Report of the Company on Form  10-KSB for the fiscal  year ended June 30,  1995,
the Company's  Quarterly  Reports on Form 10-QSB for the fiscal  quarters  ended
September  30, 1995 and December 31, 1995,  the Annual  Report of Parlux on Form
10-K for the fiscal year ended March 31, 1995 and the Quarterly Report of Parlux
on Form 10-Q for the fiscal  quarter ended December 31, 1995 are to be mailed to
each stockholder of record at the close of business on April 18, 1996.

                 INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE

                  The  following  documents,  which  have  been  filed  with the
Securities and Exchange Commission (the "Commission") by the Company (Commission
File No. 1-10320) or Parlux  (Commission File No. 0-15491),  as the case may be,
pursuant to the  Securities  Exchange  Act of 1934,  as amended  (the  "Exchange
Act"), are incorporated by reference in this Proxy Statement:

     1.   Annual Report on Form 10-KSB for the fiscal year ended June 30, 1995.

     2.   Quarterly  Reports  on Form  10-QSB  for  the  fiscal  quarters  ended
          September 30, 1995 and December 31, 1995.

     3.   Annual  Report of Parlux on Form 10-K for the fiscal  year ended March
          31, 1995.

     4.   Quarterly  Report of Parlux on Form 10-Q for the fiscal  quarter ended
          December 31, 1995.

                  Any statement incorporated by reference herein shall be deemed
to be modified or superseded for purposes of this Proxy  Statement to the extent
that a statement  contained herein or in any other  subsequently  filed document
which also is or is deemed to be  incorporated  by reference  herein modifies or
supersedes such statement.  Any statement so modified or superseded shall not be
deemed, except as so modified or superseded,  to constitute a part of this Proxy
Statement.

                                                   1

<PAGE>



                                VOTING SECURITIES

                  The Board of  Directors  has fixed  the close of  business  on
April 18, 1996 as the record date for the determination of stockholders entitled
to notice of, and to vote at, the meeting.  Only  stockholders  of record at the
close of  business  on that date will be  entitled to vote at the meeting or any
and all adjournments  thereof.  As of April 18, 1996, the Company had issued and
outstanding 4,419,548 shares of common stock, the Company's only class of voting
securities outstanding.  Each stockholder of the Company will be entitled to one
vote for each share of common stock  registered  in his name on the record date.
The  presence,  in person or by proxy,  of a majority of all of the  outstanding
shares of common stock constitutes a quorum at the meeting.

                  The following table sets forth certain information as of April
18, 1996, except as indicated below, with respect to (i) those persons or groups
known to the Company to  beneficially  own more than 5% of the Company's  common
stock, (ii) each director and nominee for director, (iii) each executive officer
whose compensation  exceeded $100,000 in fiscal 1995, and (iv) all directors and
officers as a group. The information is determined in accordance with Rule 13d-3
promulgated  under the  Securities  Exchange Act of 1934 based upon  information
furnished  by the persons  listed or  contained in filings made by them with the
Securities  Exchange  Commission.  Except as indicated  below,  the stockholders
listed possess sole voting and investment power with respect to their shares.

                                          Amount and
                                          Nature of
                                          Beneficial 
Beneficial Owner                          Ownership           Percent of Class
- ----------------                          --------------      ----------------
Richard Barrie and Lynn Barrie..........   505,223(1)              11.4%
Anthony Silverman.......................   294,277(2)(9)            7.0%
Peter T. Pochna.........................    28,045(3)                *
Arch Nadler.............................    23,667(4)                *
Ronald Stein............................    17,834(5)(9)             *
Stephen T. Meadow.......................    18,834(6)(9)             *
Charles D. Snead, Jr....................         0(7)               --

All Directors and Executive Officers
as a Group (7 persons)..................   574,769(8)(9)           12.8%


- ---------------------------------

*        Less than one percent.

(1)      Richard and Lynn  Barrie are  married.  The number of shares  indicated
         includes (i) 477,400 shares owned by Richard Barrie, who possesses sole
         voting and  investment  power with respect to such  shares;  (ii) 4,823
         shares owned by Lynn Barrie,  who possesses  sole voting and investment
         power with respect to such shares;  and (iii) 23,000 shares issuable to
         Lynn Barrie upon the exercise of presently  exercisable  options, as to
         which she will possess sole voting and  investment  power upon exercise
         of such options. Mr. and Mrs. Barrie's business address is 15 Executive
         Boulevard, Orange, Connecticut 06477.

(2)       Includes  (i)  173,334  shares  issuable  to Mr.  Silverman  upon  the
          conversion  of  $390,000   principal   amount  of  the  Company's  10%
          Convertible  Subordinated  Promissory  Notes  (the  "Notes")  and (ii)
          69,276  shares  issuable  upon the exercise of  presently  exercisable
          warrants.  Does not include shares issuable upon conversion of accrued
          but  unpaid  interest  on  the  Notes  held  by  Mr.  Silverman.   Mr.
          Silverman's  business  address is 11811 N. Tatum  Boulevard,  Phoenix,
          Arizona 85028.  The  information in this footnote is as of February 1,
          1994 and was  derived  from Mr.  Silverman's  Schedule  13D dated that
          date.

(3)       Includes  15,000  shares  issuable to Mr.  Pochna upon the exercise of
          presently exercisable options.

(4)       Includes  23,000  shares  issuable to Mr.  Nadler upon the exercise of
          presently exercisable options.

                                                   2

<PAGE>



     (5)  Includes 2,500 shares owned by Contemporary  Sales Inc.  Pension Trust
          (the "Trust") for the benefit of Mr. Stein. Also includes 8,667 shares
          issuable to the Trust for the benefit of Mr. Stein upon  conversion of
          $19,500  principal  amount of Notes.  Does not include shares issuable
          upon  conversion  of accrued but unpaid  interest on the Notes held by
          the Trust for the benefit of Mr. Stein.  Mr. Stein's  business address
          is 15 Executive Boulevard, Orange, Connecticut 06477.

     (6)  Includes  1,500 shares owned by the Rosalyn M. Meadow,  P.C.,  Defined
          Benefit  Pension Plan for the benefit of Rosalyn M. Meadow,  his wife.
          Also  includes  17,334  shares  issuable  upon  conversion  of $39,000
          principal  amount of Notes.  Does not  include  shares  issuable  upon
          conversion  of accrued  but unpaid  interest  on the Notes held by Mr.
          Meadow.  Mr.  Meadow's  business  address is 5611  North 16th  Street,
          Phoenix, Arizona 85016.

     (7)  Mr. Snead's  business  address is c/o Stone  Gatehouse,  37637 N. Pima
          Road, Scottsdale, Arizona 85262.

     (8)  Includes an  aggregate  of 69,667  shares  issuable  to the  Company's
          directors and executive officers as follows:  (i) 61,000 issuable upon
          exercise of presently  exercisable options; and (ii) 8,667 shares upon
          conversion  of $19,500  principal  amount of Notes.  Does not  include
          shares  issuable upon conversion of accrued but unpaid interest on the
          Notes.

     (9)  The  number  of  shares  issuable  upon  conversion  of the  Notes  is
          calculated at the current stated  conversion  price of $2.25 per share
          and does not give effect to the Company's  proposed  exchange with the
          holders  of the  Company's  outstanding  and past due  Notes.  See the
          discussion set forth under the caption "The Proposed Exchange."

                           PROPOSAL I: SALE OF ASSETS

         The Company  proposes to sell  virtually  all of its assets (the "Asset
Sale") to Parlux  Fragrances,  Inc. in  consideration  for  $750,000 in cash and
370,000  shares of the common  stock,  par value $.01 per share,  of Parlux (the
"Parlux  Stock"),  pursuant to the terms of an Asset Purchase  Agreement,  dated
January 31, 1996, between the Company and Parlux.

Reasons for the Transaction

         The  Company  is in  default  under  the  terms of its 10%  Convertible
Subordinated  Promissory  Notes (the "Notes") and the entire principal amount of
$5,157,750,  together with accrued  interest  thereon  ($560,905 at December 31,
1995) is  currently  due and payable.  At December  31, 1995,  the Company had a
negative net worth of $14,244.  The Company does not have the ability to pay the
amounts due on the Notes.

         For the past nine  months,  the  Company  has sought  out and  explored
various  proposals  to obtain  additional  financing,  to combine the  Company's
operations  with  other  companies  by  merger or  consolidation  or to sell the
Company's  operations.  None of those  proposals  (other than the proposed Asset
Sale) came to fruition.

         The  Company  will  proceed  with the Asset Sale only if  holders  (the
"Noteholders") of at least $5,001,750 aggregate principal amount  (approximately
97% of the principal amount outstanding) of the Notes approve the Asset Sale and
tender  their  Notes for  exchange  in  connection  with the  Proposed  Exchange
described  below,  and  holders of a majority of the  outstanding  shares of the
Company's outstanding common stock approve the Asset Sale.

         The Company is proposing to exchange (the "Proposed Exchange") for each
$19,500  principal  amount  Note  (each,  a  "Note")  two  shares  of its  newly
designated  Series A Preferred  Stock,  par value $.01 per share (the "Preferred
Shares"),  and 2,300 shares of the Company's  common stock,  par value $.005 per
share (the "Common Shares" and together with the Preferred Shares, the "Exchange
Shares"). The Company will conclude the Proposed Exchange only if the holders of
at least $5,001,750 principal amount of Notes tender their Notes for exchange in
connection therewith.  The Company is currently seeking the tender of Notes from
its Noteholders in connection with the Proposed Exchange.
See "The Proposed Exchange."

         There can be no assurance that the  Noteholders  will approve the Asset
Sale by tendering their Notes in the Proposed  Exchange.  However,  if the Asset
Sale and the Proposed Exchange are completed in accordance with their

                                                   3

<PAGE>



terms,  some  value  will be  preserved  for the  Company's  stockholders.  Upon
completion  of the Asset Sale and the Proposed  Exchange,  once the Parlux Stock
has  been  registered  for  resale,   the  stockholders  will  own  stock  in  a
publicly-held  corporation  with  liquid  assets  (the  value of  which  will be
determined  by the then current  market price of the Parlux  Stock) and no known
liabilities  other than those  accruing for current  expenses and the  Company's
obligation  to  redeem  the  Preferred  Shares  as  described   below.   Such  a
publicly-held  corporation  could be used by the  stockholders as an acquisition
vehicle in the future.  See  "Business of the Company  After  Completion  of the
Asset Sale."

         In order to make the Company more attractive as an acquisition  vehicle
and to reduce  the  impact on the  Company  and the  other  stockholders  of the
issuance of the Common Shares in the Proposed Exchange,  the Company's President
and  largest  stockholder,  Richard  Barrie,  has  agreed to  contribute  to the
Company's  capital  377,400  shares of the  Company's  common  stock held by him
simultaneously with the completion of the Asset Sale and the Proposed Exchange.

         The Board of Directors believes that the only alternative to completing
the Asset Sale and the Proposed  Exchange would be a voluntary  filing under the
United  States  Bankruptcy  Code.  The  Company  believes  that in a  bankruptcy
proceeding,   the  stockholders'   equity  interest  in  the  Company  would  be
eliminated.

Business of the Company After Completion of the Asset Sale

         Subsequent  to the  completion  of the  Asset  Sale  and  the  Proposed
Exchange,  the  Company's  business  purpose  will be to identify and conclude a
business  combination with one or more entities interested in acquiring or being
acquired by the Company or to liquidate and distribute  its assets.  The Company
will be free to  investigate  businesses  of  essentially  any  kind or  nature,
including  but not  limited to,  finance,  technology,  manufacturing,  service,
research   and   development,   healthcare,    communications,    insurance   or
transportation.  The  Company  has not chosen  (nor will it choose  prior to the
completion of the Asset Sale and the Proposed  Exchange) any particular  area of
business  in which it may  propose  to engage and has not  conducted  any market
studies with respect to any business,  property or industry.  Nothing  contained
herein  is,  nor  shall it be  deemed  to be,  a  representation  regarding  the
viability  of the Company  after  completion  of the Asset Sale and the Proposed
Exchange  or of  the  availability,  viability  or  success  of  any  subsequent
acquisition or the results of operations of the Company in connection  with such
subsequent acquisition or business venture. The Company does not believe that it
will be an investment  company required to register as such under the Investment
Company Act of 1940,  as amended (the "ICA").  The Company  intends to take such
steps as may be necessary to avoid  registration as an investment  company under
the ICA.  If the Company has not  concluded  a business  combination  within the
one-year period immediately  following  completion of the Asset Sale and because
of its  continued  ownership  of the Parlux Stock or other  securities  would be
required to register or seek an exemption from  registration  under the ICA, the
Company  anticipates  that it will sell,  transfer or otherwise divest itself of
its  ownership  of the  Parlux  Stock  or  such  other  securities,  redeem  any
outstanding  Preferred Shares and make a determination  whether to liquidate and
distribute its assets or to continue to seek out viable business combinations.

Background

         On November 1, 1995,  the Company and Parlux  signed a letter of intent
under which Parlux would  purchase  virtually  all of the assets (the  "Acquired
Assets") of the Company and would assume virtually all of the liabilities of the
Company,  expressly  excluding the Company's  obligations  under the Notes.  The
purchase price for the Acquired  Assets is 370,000 shares of Parlux common stock
(giving effect to a two-for-one  stock split effected by Parlux after  executing
the letter of intent) and $750,000 in cash.  On October 31,  1995,  the high and
low sale  prices of Parlux  common  stock on the  Nasdaq  National  Market  were
$8.1875 and $8.00,  respectively  (giving effect to the two-for-one  stock split
effected by Parlux).  The high,  low and closing  sale prices for the  Company's
common stock on the Pacific Stock Exchange on the same date were each $0.25.  On
April 4, 1996,  the  closing  sale price for Parlux  common  stock on the Nasdaq
National Market was $12.625 per share.  The Company's common stock was suspended
from trading on the Pacific Stock  Exchange on April 3, 1996 because the Company
failed to satisfy certain financial requirements.  The Company's common stock is
now traded on the OTC Bulletin  Board.  On April 4, 1996, the closing sale price
for the Company's common stock on the OTC Bulletin Board was $.26.

Information Concerning Parlux

         Parlux  was  incorporated  in  Delaware  in 1984 and is  engaged in the
creation, design, manufacture,  distribution and sale of prestige fragrances and
beauty related products marketed primarily through specialty stores and national

                                                   4

<PAGE>



department stores.  Parlux's  principal  products are fragrances.  The fragrance
market is  generally  divided  into a prestige  segment  (distributed  primarily
through  department and specialty  stores) and a mass market  segment.  Parlux's
products are  positioned  primarily in the prestige  segment.  Each fragrance is
distributed in a variety of sizes and packaging. Each fragrance line also may be
complemented by beauty-related products such as soaps, deodorants, body lotions,
cremes and dusting powders.  Parlux's basic products  generally retail at prices
ranging  from  $20 to $300  per  item.  Additionally,  Parlux  manufactures  and
distributes certain brands through Perfumania Inc., an affiliated national chain
which is a leading specialty retailer of fragrances.  Currently,  Parlux engages
in the  manufacture  (through  subcontractors),  distribution  and sale of PERRY
ELLIS,  FRED HAYMAN  BEVERLY HILLS,  TODD OLDHAM,  VICKY TIEL and PHANTOM OF THE
OPERA  fragrances  and grooming  items on an  exclusive  worldwide  basis,  as a
licensee. The principal executive offices of Parlux are located at 650 S.W. 16th
Terrace,  Pompano  Beach,  Florida  33069  and its  telephone  number  is  (305)
946-7700.

Additional Information Concerning the Company and Parlux

         Information  concerning the Company,  including the Company's Financial
Statements  for the fiscal year ended June 30, 1995 and for the fiscal  quarters
ended September 30, 1995 and December 31, 1995 and the  Management's  Discussion
and Analysis with respect to such periods,  is incorporated  herein by reference
to the Company's Annual Report on Form 10-KSB for the fiscal year ended June 30,
1995 and the  Quarterly  Reports on Form  10-QSB for the fiscal  quarters  ended
September  30, 1995 and  December 31,  1995.  Copies of those  reports are being
mailed to the stockholders of the Company with this Proxy Statement.

         Additional information concerning Parlux,  including Parlux's Financial
Statements  for the fiscal year ended March 31, 1995 and for the fiscal  quarter
ended  December 31, 1995,  and the  Management's  Discussion  and Analysis  with
respect to such periods,  and the Selected  Financial  Data for the fiscal years
ended  March 31,  1991,  1992,  1993,  1994 and 1995 is  incorporated  herein by
reference to Parlux's Annual Report on Form 10-K for the fiscal year ended March
31,  1995 and the  Quarterly  Report on Form 10-Q for the fiscal  quarter  ended
December 31, 1995.  Copies of those reports are being mailed to the stockholders
of the Company with this Proxy Statement.

Summary of the Terms of the Asset Purchase Agreement

         On January 31,  1996,  the Company  and Parlux  entered  into the Asset
Purchase  Agreement.  Set forth below is a summary of the material terms of that
agreement.

         Assets to be Sold. The Company proposes to sell to Parlux virtually all
of the  assets,  properties  and  rights  owned by the  Company  or in which the
Company  has any right or  interest  (the  "Sold  Assets"),  but  excluding  (i)
corporate  accounting  journals and corporate  books of account  comprising  the
Company's  permanent  accounting and tax records,  (ii) contracts  which are not
assignable  without  the  waiver or consent of  another  party  whose  waiver or
consent is not obtained prior to the closing (the  "Closing") of the Asset Sale,
(iii) all corporate  documents  relating to the legal or financial  structure of
the  Company,  and (iv) the  rights of the  Company  under  the  Asset  Purchase
Agreement and the agreements executed in connection therewith (collectively, the
"Excluded Assets").

         Liabilities  to be Assumed by Parlux.  Parlux has agreed to assume only
the  following  liabilities  (the  "Assumed  Liabilities")  of the Company:  (i)
liabilities  under certain  leases for periods from and after the Closing;  (ii)
liabilities  of the Company set forth on the Company's  balance sheet  ("Balance
Sheet") dated  September 30, 1995 (but  expressly  excluding any liability  with
respect to the Notes) to the extent  such  liabilities  exist on the date of the
Closing (the "Closing Date"); (iii) additional liabilities of the Company of the
types  reflected  on the  Balance  Sheet as the same may  arise in the  ordinary
course of business between September 30, 1995 and the Closing Date and which are
reflected  on a  balance  sheet  dated  as of the  Closing  Date;  and  (iv) all
obligations  under  contracts,  customer  orders,  purchase  orders,  and  other
agreements and commitments that are included in the Acquired Assets.

         Liabilities  Not to Be Assumed  by Parlux.  Parlux has agreed to assume
only those  liabilities  described  above under the caption  "Liabilities  to be
Assumed by Parlux." Pursuant to the Asset Purchase Agreement Parlux is expressly
not assuming the following  liabilities  of the Company:  (i) any liability with
respect to the Notes or the Noteholders; (ii) liabilities and obligations to the
Company's  employees;  (iii) legal,  accounting and other fees,  taxes and other
expenses  incurred in  connection  with the Asset Sale;  (iv) taxes  (other than
income taxes) for periods  prior to the Closing Date and income  taxes,  for all
periods;  (v) liabilities and obligations  with respect to the Excluded  Assets;
and

                                                   5

<PAGE>



(vi) liabilities and obligations  arising from pending or threatened  litigation
or claims against the Company (collectively, the "Excluded Liabilities").

         Purchase  Price. In  consideration  of the acquisition by Parlux of the
Acquired  Assets,  Parlux will deliver to the Company at the Closing $750,000 in
cash and 370,000 shares of Parlux common stock.

         Anticipated Closing Date.  May, 1996

         Conditions to Closing. The consummation of the Asset Sale is subject to
the  approval  of (i) the  Company's  stockholders  holding  a  majority  of the
Company's  outstanding  common  stock,  (ii)  Noteholders  holding not less than
$5,001,750 in aggregate principal amount of the Notes  (approximately 97% of the
outstanding  principal amount of Notes),  and (iii) the consent of the Company's
landlord to the  assignment  to Parlux of the  Company's  lease of the Company's
facility in Orange, Connecticut.

         Covenant  Not to Compete.  Pursuant to the terms of the Asset  Purchase
Agreement  the  Company  agrees for a period of seven years not to engage in the
manufacture or sale, or licensing for  manufacture or sale, in the United States
or any foreign country, of any of the Acquired Assets.

         Indemnification.  The Company will indemnify,  defend and hold harmless
Parlux   with   respect   to  claims   caused  by  or   arising   from  (i)  any
misrepresentation, breach of warranty and breach of any term or provision of the
Asset Purchase Agreement to a maximum amount of $3,700,000,  provided such claim
is made in  writing  within  two years  after  the  Closing,  (ii) any  Excluded
Liabilities,   or  (iii)  relating  to  liabilities   (other  than  the  Assumed
Liabilities)  arising from the operation of the Company's  business prior to the
Closing of the Asset Sale.

         Parlux will  indemnify,  defend,  and hold  harmless  the Company  with
respect to claims caused by or arising from (i) any misrepresentation, breach of
warranty and breach of any term or provision  of the Asset  Purchase  Agreement,
provided such claim is made in writing within two years after the Closing,  (ii)
any Assumed  Liabilities,  or (iii) any liability  arising from the operation of
the business of the Company by Parlux after the Closing.

         No  indemnification  rights are  enforceable  by either party until the
aggregate amount of claims subject to such rights in favor of such party exceeds
$10,000,  whereupon  the  entire  amount  of such  claims  (including  the first
$10,000) shall be enforceable in full.

         Employment  Agreements.  In connection with the Asset Sale, Parlux will
enter into employment  agreements with each of Messrs.  Barrie, Buvel, Stein and
Mahoney,  each of whom are  currently  executive  officers of the  Company.  The
description  of the  employment  agreements  of each of these  individuals  with
Parlux is set forth under the caption "Interests of Certain Persons in the Asset
Sale."

         Registration  Rights  Agreement.  In  connection  with the Asset  Sale,
Parlux will  execute a  Registration  Rights  Agreement in favor of the Company.
Pursuant  to the terms of the  Registration  Rights  Agreement  and  subject  to
certain limitations set forth therein,  Parlux agrees to use its best efforts to
register  the Parlux  Stock under the  Securities  Act of 1933,  as amended (the
"Act"),  on demand and at any time Parlux proposes to register any of its equity
securities  under the Act.  Parlux  has  agreed  to pay the  costs and  expenses
incurred in connection  with the  registration of the Parlux Stock in accordance
with the terms of the Registration Rights Agreement. Following the completion of
the  Asset  Sale,  the  Company   intends  to  exercise  its  rights  under  the
Registration Rights Agreement.

         Letter  Agreement.  Pursuant to the terms of a letter agreement between
the Company and Parlux,  Parlux has agreed to permit Messrs. Barrie and Buvel to
provide  certain  services to the Company  after  completion  of the Asset Sale.
Pursuant to the letter  agreement,  Messrs.  Barrie and Buvel are  permitted and
directed to devote a reasonable amount of time and take such reasonable  actions
as may be required (i) to fulfill the Company's  obligations  under the terms of
the Asset Purchase  Agreement,  (ii) to assist the Company in completing certain
financial  statements and the audits relating  thereto,  and (iii) to assist the
Company in meeting its reporting requirements under the Exchange Act.


                                                   6

<PAGE>



Interests of Certain Persons in the Asset Sale

         In connection  with the Asset Sale,  Parlux will enter into  employment
agreements with each of Messrs.  Barrie,  Buvel, Stein and Mahoney, each of whom
are currently executive officers of the Company. A summary of the terms of those
agreements are set forth below:

         Richard  Barrie:  Mr. Barrie will be employed by Parlux in the capacity
of  President of U.S.  Operations  for an initial term ending on March 31, 1999.
Mr. Barrie's  employment with Parlux will automatically  renew for an additional
three-year  term unless notice of  non-renewal is given by either party at least
six months prior to the expiration of the initial term. Mr. Barrie's salary will
be $241,400 per annum for the period  ending March 31, 1997 and will be adjusted
each year thereafter to take account of any increase in the cost of living.  Mr.
Barrie will receive  non-qualified  stock options to purchase  180,000 shares of
Parlux common stock at an exercise price of $6.875 per share,  the closing price
of the stock on the date the  employment  agreement  was  executed.  The options
become exercisable at the rate of 60,000 shares each on March 31, 1997, 1998 and
1999 and remain  exercisable  for ten years  from the date of grant.  Parlux has
also agreed to continue to pay the premium on the Company's  "split-dollar" life
insurance  policy on Mr.  Barrie's life.  Upon the  termination of Mr.  Barrie's
employment  for any reason,  Parlux will assign and  transfer to Mr.  Barrie all
right, title and interest in and to the name "Richard Barrie Fragrances" and any
and all derivations thereof.

     Joseph Buvel:  Mr. Buvel will be employed by Parlux in the capacity of Vice
President - Finance for U.S.  Operations for an initial term ending on March 31,
1999.  Mr.  Buvel's  employment  with  Parlux  will  automatically  renew for an
additional  one-year term unless notice of  non-renewal is given by either party
at least three months prior to the  expiration of the initial term.  Mr. Buvel's
salary will be $94,200 per annum for the period  ending March 31, 1997 with such
increases  thereafter  as may be determined  by the Chief  Financial  Officer of
Parlux.

     Leo Mahoney: Mr. Mahoney will be employed by Parlux in the capacity of Vice
President - Distribution for U.S. Operations for an initial term ending on March
31, 1999. Mr. Mahoney's  employment with Parlux will automatically  renew for an
additional  one-year term unless notice of  non-renewal is given by either party
at least three months prior to the expiration of the initial term. Mr. Mahoney's
salary will be $99,900 per year for the period  ending  March 31, 1997 with such
increases  thereafter as may be determined by the Vice President - Operations of
Parlux.

     Ronald Stein:  Mr. Stein will be employed by Parlux in the capacity of Vice
President - Sales for U.S.  Operations  for an initial  term ending on March 31,
1999.  Mr.  Stein's  employment  with  Parlux  will  automatically  renew for an
additional  one-year term unless notice of  non-renewal is given by either party
at least three months prior to the  expiration of the initial term.  Mr. Stein's
salary will be $100,900 per year for the period  ending March 31, 1997 with such
increases thereafter as may be determined by the President of U.S. Operations of
Parlux.

         Each of Messrs.  Buvel,  Mahoney and Stein will  receive  non-qualified
stock  options to purchase  10,000  shares of Parlux common stock at an exercise
price of $6.875  per  share,  the  closing  price of the stock on the date their
employment agreements were executed.  The options become exercisable at the rate
of 3,333 shares each on March 31, 1997 and 1998 and 3,334 on March 31, 1999. The
stock options remain exercisable for ten years from the date of grant.

Certain Transactions Between the Company and Parlux.

         Since fiscal 1994,  the Company has performed  certain  production  and
filling  services  for Parlux.  Services  are  provided on the basis of purchase
orders  submitted by Parlux and  accepted by the  Company.  For the fiscal years
ended  June 30,  1994 and 1995 the  total  amounts  billed  to  Parlux  for such
production and filling services were $35,573 and $221,821, respectively.

         By letter  agreement  dated January 4, 1996, the Company entered into a
Warehousing  and  Distribution  Agreement  (the "W&D  Agreement")  with  Parlux.
Pursuant to the W&D Agreement,  the Company  provides  certain  warehousing  and
distribution  services to Parlux with respect to Parlux products  located at the
Company's facility in Orange,  Connecticut.  Pursuant to the W&D Agreement,  the
Company also provides Parlux with an office and certain furniture,  fixtures and
office  equipment to enable Parlux to perform certain  functions  required of it
under the terms of the W&D Agreement.  In consideration for its services and the
use of its  facilities  under the W&D  Agreement,  the  Company  receives  three
percent (3%) of the gross sales of Parlux  products  shipped from the  Company's
facility.  The W&D  Agreement  has an  initial  term of one year  and  continual
renewal options of two years each.

                                                   7

<PAGE>




         The  Company's  obligations  with  respect to  production  and  filling
services and the W&D Agreement will terminate upon the consummation of the Asset
Sale.

The Proposed Exchange

         The Notes are in default and principal and interest  thereon is and has
been due and payable. As of December 31, 1995, the total amount of principal and
accrued  interest  under the Notes was  $5,718,655.  Interest is accruing at the
default  rate of 15% per  annum.  The total  amount  of  principal  and  accrued
interest through April 30, 1996 will be $5,978,692.

         In the near  future,  the Company  will  distribute  to  Noteholders  a
Private Offering  Memorandum  pursuant to which the Company proposes to exchange
for each $19,500  principal  amount Note two  Preferred  Shares and 2,300 Common
Shares.

The Preferred Shares

     The Preferred Shares will be issued as a series of the Company's authorized
and previously  unissued preferred stock.  Pursuant to the Company's Articles of
Incorporation,  the Company is authorized  to issue up to  10,000,000  shares of
preferred  stock,  par  value  $.01  per  share,   having  "such   designations,
preferences and relative,  participating,  optional or other special rights,  or
qualifications,  limitations  or  restrictions  . . . as shall be  stated in the
resolution or resolutions  providing for the issue of each series adopted by the
Board of Directors . . . ."

         The Preferred Shares will have the following rights and privileges: The
Preferred  Shares,  as a  class,  will  have  a  preference  in  liquidation  of
$2,962,400  ($5,600 per  share).  The Company  will be  obligated  to redeem the
Preferred  Shares for an aggregate  redemption price of $2,962,400 one year from
their date of issuance.  If the Company does not effect the mandatory redemption
within such one year period,  the holders of a majority of the Preferred  Shares
will have the right to demand the  liquidation  of the Company and receive their
liquidation  preference.  The Company has the right to call the Preferred Shares
for redemption at any time after issuance for an aggregate  redemption  price of
$2,962,400.  Holders of the  Preferred  Shares will have no voting rights except
the right to vote as a class  with  respect  to (i) any sale of  Company  assets
having a fair market value of $250,000 or more,  alone or in the aggregate  with
all other sales of Company  assets,  unless all of the proceeds of such sale are
applied to the payment of the redemption price of the Preferred Shares; (ii) any
amendments to the Company's Articles of Incorporation; and (iii) the issuance of
any shares of the Company's stock (other than any issuance pursuant to currently
outstanding  rights or options) unless the Preferred  Shares will be redeemed in
connection with the transaction  pursuant to which such shares are to be issued.
For all matters on which the holders of Preferred Shares are entitled to vote as
a class,  the  affirmative  vote of holders  holding a majority of the Preferred
Shares  outstanding shall be required for approval of such matter. The Preferred
Shares have no right to dividends.

Conditions to the Proposed Exchange

         The Company will proceed with the Proposed  Exchange only if holders of
at least $5,001,750  aggregate  principal amount of Notes  (approximately 97% of
the outstanding principal amount of the Notes) approve the Asset Sale and tender
their Notes for exchange  (the "Minimum  Tenders")  pursuant to the terms of the
Proposed  Exchange.  If the Minimum Tenders are obtained,  any Note not tendered
for satisfaction will continue to be an obligation and liability of the Company.
Accordingly,  the  maximum  aggregate  principal  amount  payable  to  all  such
non-consenting  Noteholders would be $156,000 with accrued interest thereon.  As
of April 30, 1996, the principal and accrued interest for all such  non-tendered
Notes would be $180,830.

         There can be no  assurance  that the Minimum  Tenders will be obtained.
However, if the Minimum Tenders are not obtained,  the Company will not complete
the  Asset  Sale or the  Proposed  Exchange.  In such  event,  Noteholders  will
continue to be able to enforce their rights to collect the Company's obligations
to them under the Notes.  The Company  believes that the only  alternative  then
available  to the  Company  will be to file under the United  States  Bankruptcy
Code.

                                                   8

<PAGE>


<TABLE>

Pro Forma Financial Information For the Company
<CAPTION>

         The following table sets forth the Company's unaudited balance sheet at
December 31, 1995, pro forma to reflect the Asset Sale, and as further  adjusted
to reflect the completion of the Proposed Exchange.

                                                                                                 December 31, 1995
                                                                                                    (unaudited)
                                                                                                                           
<S>                                                                                 <C>                 <C>                <C>
                                                                                   Actual           Pro Forma(1)      As Adjusted(2)
ASSETS
Current Assets:
  Cash and Cash Equivalents ............................................        $   466,014         $   750,000         $   750,000
  Accounts Receivable ..................................................          1,521,149                --                  --
  Inventory and Promotional Merchandise ................................          2,324,730                --                  --
  Other Current Assets .................................................            199,996                --                  --
  Investment in Marketable Securities(3) ...............................               --             3,283,750           3,283,750
                                                                                -----------         -----------         -----------
    Total Current Assets ...............................................          4,511,889           4,033,750           4,033,750
  Fixed Assets, Net ....................................................          1,040,358                --                  --
  Debt Issuance Cost, Net ..............................................              6,302                --                  --
  Other Long Term Assets ...............................................          1,825,404                --                  --
                                                                                -----------         -----------         -----------
    Total Assets .......................................................        $ 7,383,953         $ 4,033,750         $ 4,033,750
                                                                                ===========         ===========         ===========
            LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Current Liabilities:
  Convertible Notes Payable ............................................        $ 5,157,750         $ 5,157,750         $      --
  Accounts Payable(4) ..................................................            573,676              75,000              75,000
  Accrued Expenses(5) ..................................................          1,666,771             560,905                --
                                                                                -----------         -----------         -----------
    Total Liabilities ..................................................          7,398,197           5,793,655              75,000
                                                                                -----------         -----------         -----------

Mandatory Redeemable Preferred Stock(6) ................................               --                  --             2,962,400
                                                                                -----------         -----------         -----------
Stockholders' Equity (Deficit):
  Preferred Stock, 0.01 par value, 10,000,000 shares ...................               --                  --                  --
    authorized, 529 shares outstanding as Mandatory
      Redeemable Preferred Stock (6)
  Common Stock, $0.005 par value, 16,666,667 shares ....................             22,097              22,097              23,252
    authorized, 4,419,548 (Actual and Pro Forma) and
    4,650,498 (as adjusted) issued and outstanding
  Additional Paid-In Capital ...........................................          6,982,738           7,041,707           7,076,638
  Accumulated Deficit ..................................................         (7,019,079)         (8,764,740)         (6,103,540)
  Treasury Stock .......................................................               --               (58,969)               --
                                                                                -----------         -----------         -----------
    Total Stockholders' Equity (Deficit) ...............................            (14,244)         (1,759,905)            996,350
                                                                                -----------         -----------         -----------
      Total Liabilities and Stockholders' Equity (Deficit) .............        $ 7,383,953         $ 4,033,750         $ 4,033,750
                                                                                ===========         ===========         ===========

<FN>
- ----------------------------
(1)  Pro forma to reflect the sale of virtually all assets to, and assumption of
     virtually  all  liabilities  by,  Parlux in exchange for 370,000  shares of
     Parlux common stock (valued at $8.875 per share, the per share market price
     on the Nasdaq  National  Market of the Parlux  common stock on December 31,
     1995;  at April 4, 1996 such price was $12.625) and $750,000 in cash.  Also
     adjusted to reflect the contribution by Richard Barrie of 377,400 shares of
     the Company's common stock to the capital of the Company.

(2)  As  adjusted to reflect the  issuance of 529  Preferred  Shares and 608,350
     Common Shares to the  Noteholders in payment of $3,057,455 of principal and
     interest due (of which  $2,962,400 is attributable to the Preferred  Shares
     and $95,055 is  attributable  to the Common  Shares) and in settlement  and
     extinguishment  of the remaining  $2,661,200  principal and interest due at
     December 31, 1995.  Assumes exchange of all outstanding  Notes for Exchange
     Shares.  It should be noted,  however,  that the Company will  complete the
     Asset  Sale  and the  Proposed  Exchange  only if the  holders  of at least
     $5,001,750  principal  amount of Notes (the "Minimum  Tenders") tender such
     Notes in the  Proposed  Exchange.  If the Minimum  Tenders are  received in
     connection with the Proposed  Exchange,  up to $156,000 principal amount of
     Notes may remain  outstanding after the completion of the Proposed Exchange
     which  would  remain an  obligation  and  liability  of the Company and the
     Company  would  issue  fewer  Exchange  Shares.  The  closing  price of the
     Company's  common stock on the Pacific Stock  Exchange on December 31, 1995
     was $0.15625.

(3)  Represents Parlux Stock.

(4)  Pro forma and as adjusted  accrual for expenses of the transaction and
     other  costs.  (5) Includes  accrued  interest at December 31, 1995 on
     Notes of $560,905.

(5)  Includes accrued interest at December 31, 1995 on Notes of $560,905

(6)  As adjusted for the issuance of the Preferred Shares having a mandatory
     redemption feature.
</FN>
</TABLE>
                                                   9

<PAGE>



<TABLE>

Pro Forma Financial Information For Parlux and the Company Combined
<CAPTION>

     The following  tables set forth the unaudited  Statements of Operations for
the Company and Parlux  (other than the actual  information  for Parlux at March
31, 1995,  which is audited)  for the periods  ended March 31, 1995 and December
31, 1995, pro forma to reflect the Asset Sale, and pro forma as adjusted to give
effect to certain  operating  provisions which would, on a pro forma basis, have
been experienced by the Company and Parlux on a combined basis.

                                                                          Twelve Months Ended March 31, 1995
                                                                         (Unaudited Except Parlux Actual) ($)
                                      ---------------------------------------------------------------------------------------------
                                                       Actual                                                 Pro Forma
                                      ----------------------------------------       ----------------------------------------------
                                                                                                                           As
                                            Company             Parlux               Combined         Adjustments      Adjusted
<S>                                           <C>                <C>                   <C>                 <C>            <C>  

Net Sales
  Unaffiliated Customers                     18,304,252           22,978,956         41,283,208                        41,283,208
  Affiliated                                                      15,230,143         15,230,143                        15,230,143
                                      ---------------------------------------------------------------------------------------------
                                             18,304,252           38,209,099         56,513,351                        56,513,351
Cost of Sales                                 5,799,252           14,957,475         20,756,727      (29,491)(1)       20,727,236
                                      ---------------------------------------------------------------------------------------------
     Gross Profit                            12,505,000           23,251,624         35,756,624       29,491           35,786,115
                                      ---------------------------------------------------------------------------------------------
Operating Expenses
  Advertising and Promotion                   8,093,269            7,248,839         15,342,108                        15,342,108
  Selling, General and
    Administrative                            5,429,135            8,179,032         13,608,167       602,500(2)       14,210,667
  Royalties                                     281,542              823,223          1,104,765                         1,104,765
                                      ---------------------------------------------------------------------------------------------
     Total Operating Expenses                13,803,946           16,251,094         30,055,040       602,500          30,657,540
                                      ---------------------------------------------------------------------------------------------
  Operating Income (Loss)                   (1,298,946)            7,000,530          5,701,584      (573,009)          5,128,575
                                      ---------------------------------------------------------------------------------------------
Other Income(Expense)
  Interest Expense - Net                      (456,949)          (1,189,658)        (1,646,607)                        (1,646,607)
  Miscellaneous Income -Net                     140,260                                140,260       (29,491)(1)          110,769
  Exchange Losses                                                  (300,661)          (300,661)                          (300,661)
                                      ---------------------------------------------------------------------------------------------
   Total Other Income(Expense)                (316,689)          (1,490,319)        (1,807,008)      (29,491)          (1,836,499)
                                      ---------------------------------------------------------------------------------------------
Income(Loss) Before
 Provision for Income Taxes                 (1,615,635)            5,510,211         3,894,576      (602,500)           3,292,076
Provision for Income Taxes                            0          (1,279,000)        (1,279,000)      375,012(3)          (903,988)
                                      ---------------------------------------------------------------------------------------------
  Net Income(Loss)                          (1,615,635)            4,231,211         2,615,576      (227,488)           2,388,088
                                      =============================================================================================
- ---------------

<FN>

     (1)  Pro forma adjustment to eliminate the activities carried out on behalf
          of Parlux by the Company  and  included in Cost of Sales by Parlux and
          Other Income by the Company. 

     (2)  Pro  forma  adjustment  to give  effect  to (i)  additional  value  of
          approximately $1 million to be attributed to the Company by Parlux and
          amortized  over a five year period or  $200,000  per year and (ii) the
          compensation  expense to be recorded by Parlux in connection  with the
          grant of an aggregate  of 210,000  options to employees of the Company
          at an exercise  price of $6.875 per share as compared to the per share
          price of $12.625 of the Parlux Common Stock on April 4, 1996.

     (3)  Pro forma  adjustment to give effect to the income tax provision which
          would on a pro forma basis have been  experienced by the entities on a
          combined basis at the effective income tax rate of Parlux.
</FN>
</TABLE>
                                                   10

<PAGE>



<TABLE>

                                                                          Nine Months Ended December 31, 1995
                                                                                    (Unaudited) ($)
                                      ---------------------------------------------------------------------------------------------
                                                       Actual                                           Pro Forma
                                      ---------------------------------------------------------------------------------------------
                                              Company             Parlux        Combined         Adjustments          As Adjusted
<S>                                            <C>                  <C>           <C>              <C>                   <C>
                   
Net Sales
  Unaffiliated Customers                                          30,182,604    41,158,568                             41,158,568
  Affiliated Customers                       10,975,964           17,785,404    17,785,404                             17,785,404
                                      ---------------------------------------------------------------------------------------------
                                             10,975,964           47,968,008    58,943,972                             58,943,972
Cost of Sales                                 3,236,507           18,710,129    21,946,636       (227,803)(1)          21,718,833
                                      ---------------------------------------------------------------------------------------------
     Gross Profit                             7,739,457           29,257,879    36,997,336        227,803              37,225,139
                                      ---------------------------------------------------------------------------------------------
Operating Expenses
  Advertising and Promotion                   5,018,249            8,898,663    13,916,912                             13,916,912
  Selling, General and
    Administrative                            3,473,400            7,638,207    11,111,607         451,875(2)          11,563,482
  Royalties                                     468,612            1,091,228     1,559,840                              1,559,840
                                      ---------------------------------------------------------------------------------------------
     Total Operating Expenses                 8,960,261           17,628,098    26,588,359         451,875             27,040,234
                                      ---------------------------------------------------------------------------------------------
  Operating Income (Loss)                   (1,220,804)           11,629,781    10,408,977        (224,072)            10,184,905
                                      ---------------------------------------------------------------------------------------------
Other Income(Expense)
  Interest Expense - Net                      (397,887)          (1,414,240)    (1,812,127)                            (1,812,127)
  Miscellaneous Income -Net                   1,041,947              117,802     1,159,749        (227,803)(1)            931,946
                                      ---------------------------------------------------------------------------------------------
   Total Other Income(Expense)                  644,060          (1,296,438)      (652,378)       (227,803)              (880,181)
                                      ---------------------------------------------------------------------------------------------
Income(Loss) Before
 Provision for Income Taxes                   (576,744)           10,333,343     9,756,599        (451,875)             9,304,724
Provision for Income Taxes                            0          (3,457,140)    (3,457,140)        192,956(3)          (3,264,184)
                                      ---------------------------------------------------------------------------------------------
  Net Income(Loss)                            (576,744)            6,876,203     6,299,459        (258,919)             6,040,540
                                      =============================================================================================


<FN>
- ------------------

     (1)  Pro forma adjustment to eliminate the activities carried out on behalf
          of Parlux by the Company  and  included in Cost of Sales by Parlux and
          Other Income by the Company.

     (2)  Pro  forma  adjustment  to give  effect  to (i)  additional  value  of
          approximately $1 million to be attributed to the Company by Parlux and
          amortized  over a five year period or  $200,000  per year and (ii) the
          compensation  expense to be recorded by Parlux in connection  with the
          grant of an aggregate  of 210,000  options to employees of the Company
          at an exercise  price of $6.875 per share as compared to the per share
          price of $12.625 of the Parlux Common Stock on April 4, 1996.

     (3)  Pro forma  adjustment to give effect to the income tax provision which
          would on a pro forma basis have been  experienced by the entities on a
          combined basis at the effective income tax rate of Parlux.
</FN>
</TABLE>
Accounting Treatment and Certain Federal Income Tax Considerations

     The Asset Sale will be treated as a sale for accounting purposes.

     The  following   summary   describes  the  principal   federal  income  tax
considerations  applicable to the Company and those  Noteholders  who tender the
Notes held by them in the Proposed Exchange.  Such summary is based upon current
provisions  of  the  Internal  Revenue  Code  (the  "Code")  and  administrative
interpretations  thereof,  which are  subject to change.  Moreover,  substantial
uncertainties  exist with  respect to various tax  consequences  of the Proposed
Exchange,  and no ruling has been or will be requested from the Internal Revenue
Service (the  "Service")  on any tax matter  concerning  the Proposed  Exchange.
Accordingly, no absolute assurances can be given with respect to certain federal
income tax consequences of the Proposed  Exchange.  In addition,  the discussion
below does not address the state,  local or foreign  tax  consequences  that may
result from the Proposed  Exchange,  nor does it deal with taxpayers  subject to
special  treatment  under the federal income tax laws (such as foreign  persons,
life insurance  companies,  tax-exempt  organizations,  and taxpayers subject to
alternative minimum tax).
                                                   11
<PAGE>



     Tax  Consequences  to the  Company  of the Asset  Sale.  The  Company  will
recognize gain or loss upon the sale of virtually all of the Company's assets to
Parlux  measured by the difference  between (i) the aggregate of the $750,000 in
cash and the market  value of 370,000  shares of Parlux  Stock  received  by the
Company plus the  liabilities  assumed by Parlux and (ii) the adjusted tax basis
to the Company of the assets sold. The Company believes that it will recognize a
loss on this sale.

     Tax Consequences to the Company of the Proposed Exchange. Completion of the
Proposed   Exchange  will  reduce  the  amount  of  the  Company's   outstanding
indebtedness.  Under the  Proposed  Exchange,  the Company  proposes to exchange
Preferred Shares with a liquidation preference and mandatory redemption price of
approximately $2,960,000 (discounted present value of approximately  $2,680,000)
and Common Shares having a market value of  approximately  $95,000 (based on the
$.15625  closing sale price of the  Company's  common stock on the Pacific Stock
Exchange on December 31, 1995),  together having a market value of approximately
$2,775,000,  for Notes with a principal outstanding balance and accrued interest
of $5,718,655 as of December 31, 1995. A debtor  generally  realizes  income for
federal  income tax purposes when its debt is canceled in exchange for an amount
less  than the  adjusted  issue  price of the  debt.  The  cancellation  of debt
resulting from the Proposed Exchange may therefore be approximately  $2,700,000.
Under  the  Code,  however,  income  will not be  recognized  as a  result  of a
cancellation  of indebtedness to the extent the amount of debt canceled does not
exceed the amount by which the debtor is insolvent.  "Insolvency" is defined for
this  purpose as the excess of the  debtor's  liabilities  over the fair  market
value of its assets  immediately  before the  cancellation of  indebtedness.  It
appears from the Company's  December  31,1995 pro forma balance sheet that it is
insolvent to the extent of approximately $1,760,000 and that to this extent, the
Company  should  be able to  avoid  recognition  of  taxation  income  from  the
cancellation   of   indebtedness.   The  excess   $900,000  of  cancellation  of
indebtedness  income  would  likely  be offset by the  Company's  available  net
operating loss  carryforward for purposes of the regular income tax. The Company
at  present  has  available  approximately  $6,500,000  of  net  operating  loss
carryovers  for  Federal  income  tax  purposes.  The  Company's  remaining  net
operating loss  carryforward  would have to be reduced by an amount equal to the
amount of cancellation of indebtedness  income not being  recognized  because of
the insolvency rule.

     Tax Consequences to the Noteholders of the Proposed Exchange.  The Proposed
Exchange is to be treated as a taxable exchange under Code Sec. 1001(a).  As the
Notes were  issued  with a maturity  date of less than three  years they are not
"securities" under the Code and the exchange does not qualify for treatment as a
tax-free  recapitalization under Code Sec. 354. A Noteholder will recognize gain
or loss upon the exchange of Notes  measured by the  difference  between (i) the
fair market value of the Preferred  Shares and Common  Shares  received and (ii)
the Noteholder's tax basis in the Notes. Under the Proposed Exchange the Company
proposes  to  deliver  two  Preferred  Shares and 2,300  Common  Shares for each
$19,500 principal amount Note  outstanding.  Assuming that the fair market value
of each Preferred Share is $5,069 (the discounted  present value of the right to
receive  $5,600 one year from issuance) and of each Common Share is $.15625 (the
closing sale price of the Company's  common stock on the Pacific Stock  Exchange
on  December  31,  1995),  a holder of a $19,500  principal  amount Note will be
receiving  Preferred  Shares and Common  Shares  having an  estimated  aggregate
market value of $10,497.

     Any such gain or loss will  generally  be  long-term  capital gain or loss,
provided the Notes have been held for more than one year and were capital assets
in the  hands of the  Noteholder.  No part of the  property  being  received  in
exchange should be treated as attributable to accrued but unpaid interest.

     The  Noteholders'  tax bases in the  Preferred  Shares  and  Common  Shares
received will be their respective fair market value, and the holding period will
begin, on the day the Notes are exchanged.

Consents and Approvals of Federal and State Regulatory Agencies.

     There  are no  Federal  or  State  regulatory  requirements  which  must be
complied with nor is the approval of any such  regulatory  agency required to be
obtained in connection with the Asset Sale.

Absence of Appraisal Rights

     Nevada law governs  stockholders' rights in connection with the Asset Sale.
Under the  applicable  provisions  of the Nevada  General  Corporation  Law, the
Company's  stockholders  will have no right in connection with the Asset Sale to
dissent and seek appraisal of their shares of the Company's common stock.


                                                   12

<PAGE>



Vote Required and Recommendation of the Board of Directors

     The  affirmative  vote of  stockholders  holding at least a majority of the
outstanding  common  stock is required  for  approval  of the Asset Sale.  Under
applicable  law, for purposes of determining  whether the proposal  received the
requisite number of votes,  abstentions and broker non-votes will not be counted
and will have the same effect as a vote  against  the  proposal.  The  Company's
officers,  directors and nominees for director,  and Mr.  Anthony  Silverman,  a
beneficial owner of more than 5% of the Company's outstanding common stock, have
indicated  that they will  vote all of the  shares  held by them in favor of the
Asset Sale. See the information set forth under the caption "Voting Securities."

     The Board of Directors  unanimously  recommends that the stockholders  vote
FOR approval of the Asset Sale.



                        PROPOSAL II: SALE OF PARLUX STOCK

     After  completion  of the Asset Sale,  the Company  intends to exercise the
registration  rights granted to it by Parlux in accordance with the terms of the
Registration  Rights  Agreement  executed  in  connection  with the Asset  Sale.
Pursuant to the terms of the Registration Rights Agreement,  Parlux will pay all
costs,  expenses  and fees in  connection  with the  registration  of the Parlux
Stock.  Brokerage  commissions,  if any,  attributable to the sale of the Parlux
Stock will be borne by the Company.

     The  Company,  from time to time,  may effect  sales of the Parlux Stock in
transactions  (which may include  block  transactions)  in the  over-the-counter
market, in negotiated transactions, through the writing of options on the Parlux
Stock,  or a  combination  of such methods of sale, at fixed prices which may be
changed,  at  market  prices  prevailing  at the  time of sale or at  negotiated
prices.  The Company may effect such  transactions  by selling the Parlux  Stock
directly to purchasers or to or though broker-dealers which may act as agents or
principals.  Such  broker-dealers  may  receive  compensation  in  the  form  of
discounts, concessions, or commissions from the Company and/or the purchasers of
such securities for whom such  broker-dealers  may act as agents or to whom they
sell as principal, or both (which compensation as to a particular  broker-dealer
might be in excess of customary commissions). The Company may also elect to sell
the Parlux Stock pursuant to one or more exemptions from registration  under the
Securities Act.

Vote Required and Recommendation of the Board of Directors

     The  affirmative  vote of  stockholders  holding at least a majority of the
outstanding  common stock is required  for approval of the proposed  sale of the
Parlux Stock.  Under  applicable  law, for purposes of  determining  whether the
proposal  received  the  requisite  number  of  votes,  abstentions  and  broker
non-votes  will not be counted and will have the same  effect as a vote  against
the proposal.

     The Board of Directors  unanimously  recommends that the stockholders  vote
FOR approval of the sale of the Parlux Stock.



                                                   13

<PAGE>




       PROPOSAL III: AMENDMENT TO THE COMPANY'S ARTICLES OF INCORPORATION

     Pursuant  to the terms of the Asset  Purchase  Agreement,  the  Company has
agreed to change its name  effective on, or as soon as  practicable  after,  the
Closing  Date to a new name  which does not  include  the term  "Richard  Barrie
Fragrances" or any variation  thereof or similar name and which otherwise is not
likely to be confused  with the  Company's  present  name,  in order to make the
Company's present name available to Parlux. As a result,  the Board of Directors
has unanimously declared it advisable and recommends that the Company's Articles
of  Incorporation  be amended to change the name of the Company,  subject to and
contingent upon  completion of the Asset Sale, from "Richard Barrie  Fragrances,
Inc." to "FBR Capital Corporation."

     If the proposed  amendment to the Company's  Articles of  Incorporation  is
approved by the  stockholders  and the Asset Sale is completed,  such  amendment
will become  effective  upon the filing with the Secretary of State of the State
of Nevada of an Amendment to the Articles of Incorporation.

Vote Required and Recommendation of the Board of Directors

     The  affirmative  vote of  stockholders  holding at least a majority of the
outstanding  common stock is required for adoption of this Proposal  III.  Under
applicable law,  abstentions  and broker  non-votes will not be counted and will
have the same effect as a vote against the proposal.

     The Board of Directors  recommends  that you vote FOR the proposal to amend
the Company's Articles of Incorporation to effect a change in the Company's name
to FBR Capital Corporation.




                                                   14

<PAGE>



                       PROPOSAL IV: ELECTION OF DIRECTORS

     Immediately  after the  completion  of the Asset Sale each of the Company's
current directors will resign their position and the Board of Directors shall be
reconstituted  to consist of the two  directors  elected at the meeting.  At the
meeting,  two directors are to be elected to take office  immediately  after the
consummation  of the  Asset  Sale  and to serve as such  until  the next  Annual
Meeting of Stockholders  and until their  respective  successors are elected and
qualified. The proxies given pursuant to this solicitation will be voted for the
two nominees -- Stephen T. Meadow and Charles D. Snead,  Jr. -- unless authority
is withheld.  Should a nominee become  unavailable  for any reason,  the proxies
will be voted for an  alternative  nominee to be determined by the persons named
in the proxy.  The Board of Directors  has no reason to believe that any nominee
will be  unavailable.  Proxies  cannot be voted for a greater  number of persons
than the number of  nominees  named.  Assuming  the  presence  of a quorum,  the
directors  shall be elected by a plurality of the votes cast at the meeting with
respect to the election of directors. "Plurality" means that the individuals who
receive the largest  number of votes cast "For" are elected as  directors  up to
the maximum  number of  directors  to be elected.  Consequently,  any shares not
voted  "For" a  particular  director  (whether  as a result  of a  direction  to
withhold  authority or a broker non-vote) will not be counted in such director's
favor.

Information Concerning Directors, Nominees for Director and Executive Officers

     Nominees for Director and Proposed Executive Officer


Name                        Age            Position

Stephen T. Meadow           68            Nominee for Director
Charles D. Snead, Jr.       63            Nominee for Director and
                                            Proposed President and
                                            Chief Executive Officer



     Current Directors and Executive Officers


Name               Age         Position

Lynn Barrie        48          Director and Secretary
Richard Barrie     53          Director, President and Chief Executive Officer
Arch Nadler        71          Director
Peter T. Pochna    54          Director
Joseph Buvel       34          Vice President - Finance, Treasurer and Chief
                                Financial Officer
Leo Mahoney        48          Vice President - Operations
Ronald Stein       53          Vice President - Sales


       Officers are elected  annually by the Board of Directors and serve at the
discretion of the Board.

       Stephen T. Meadow has been  nominated  for  election as a director of the
Company at the Special Meeting to take office  immediately  after the completion
of the Asset Sale.  Since 1962,  Mr.  Meadow has been an attorney in the private
practice of law specializing in the field of corporate and securities law.

     Charles D. Snead,  Jr. has been nominated for election as a director of the
Company at the Special Meeting to take office  immediately  after the completion
of  the  Asset  Sale.  Mr.  Snead  is an  attorney  and a  business  and  mining
consultant.  From October 1991 through June 1994,  Mr. Snead was Chairman of the
Board of Siskon Gold Corporation.  Since 1991, Mr. Snead has been, and continues
to be, a director of Siskon Gold  Corporation.  Prior to October 1991, Mr. Snead
was President and Chief Executive Officer of Callahan Mining Corporation.

     Mrs.  Barrie has served as Secretary and as a director of the Company since
its inception in 1988.  From 1986 to 1988,  Mrs. Barrie was a Vice President and
principal of Richard Barrie Enterprises, a consulting company specializing

                                                   15

<PAGE>



in the  cosmetics  and  toiletries  industry  and,  since 1981,  has been a
homemaker. Mrs. Barrie is the wife of Richard Barrie.

       Mr. Barrie has served as President and chief  executive  officer and as a
director of the Company  since its  inception  in 1988.  From 1986 to 1988,  Mr.
Barrie was President and a principal of Richard Barrie Enterprises, a consulting
company  specializing  in the cosmetics and  toiletries  industry.  From 1984 to
1986,  Mr.  Barrie was  employed or retained in a  consultant  capacity by Carme
International,  Inc., a subsidiary  of Carme,  Inc., a  manufacturer  of natural
health and beauty aids and a distributor of natural food and cosmetic  products.
From 1963 to 1984,  Mr.  Barrie was  employed in various  sales,  marketing  and
executive capacities by Faberge  Incorporated,  serving as Senior Executive Vice
President  and  Chief  Operating  Officer  from  1980 to  1984,  Executive  Vice
President -- Marketing and Sales from 1970 to 1980,  Vice President of Marketing
and Sales -- Retail  and Salon  Divisions  from 1967 to 1970,  Sales  Manager --
Retail and Salon  Divisions  from 1966 to 1967,  and in various sales  positions
from 1963 to 1966. In addition,  Mr. Barrie served as member of Faberge's  Board
of Directors from 1970 to 1984.  During Mr.  Barrie's  years at Faberge,  he was
involved  in  the  development  (including  formulations,   packaging,  pricing,
distribution  and marketing) and  introduction of many well known and successful
product lines, including the BABE fragrance line, which in its first year became
Faberge's largest selling women's fragrance worldwide.  BABE received two awards
from the Fragrance Foundation for its 1976 launch: Most Successful  Introduction
of a Women's Fragrance in Popular  Distribution,  and Best Advertising  Campaign
for Women's Fragrance.  Mr. Barrie also supervised Faberge's introduction of the
popular BRUT 33 toiletry line for Faberge.  Mr.  Barrie's role for this toiletry
line included obtaining Joe Namath's endorsement and promotional assistance.  In
1977,  Mr. Barrie signed Farrah  Fawcett to a promotional  contract with Faberge
for the Farrah  Fawcett  hair  product  and  fragrance  lines.  Mr.  Barrie also
supervised  the  expansion of the Faberge  Organics Hair Care line from a beauty
salon  line to a  successful  retail  line.  Mr.  Barrie is the  husband of Lynn
Barrie.  Effective  immediately  after the  consummation  of the Asset Sale, Mr.
Barrie  will resign from being a director,  the  President  and Chief  Executive
Officer of the Company.

       Mr.  Nadler  became a director of the Company upon the  completion of the
Company's  initial  public  offering in March 1989.  Mr.  Nadler has managed his
private investments since retiring in December 1984 as Chairman of the Board and
Chief Executive Officer of Nadler & Larimer  Advertising  Agency, an advertising
agency with offices in New York and London, which he founded in 1962.

     Mr.  Pochna  became a director of the Company  upon the  completion  of the
Company's  initial public  offering in March 1989. Mr. Pochna has been a private
investor  and  financial  consultant  to small  businesses  during the past five
years.

       Mr. Buvel became Vice President - Finance,  Treasurer and Chief Financial
Officer of the Company in February 1994 after  becoming  employed by the Company
in December 1993 following completion of the Company's transaction with Muelhens
Inc., which manufactured and distributed fragrance,  cosmetic and skin treatment
products. From 1984 to December 1993, Mr. Buvel was employed by Muelhens Inc. in
a variety of financial positions,  the last two years serving as Chief Financial
Officer.

       Mr. Mahoney became Vice President - Operations of the Company in February
1994  after  becoming  employed  by  the  Company  in  December  1993  following
completion  of the Company's  transaction  with Muelhens Inc. From April 1991 to
December  1993,  Mr.  Mahoney was Director of  Operations  of Muelhens Inc. From
January 1990 to April 1991,  Mr. Mahoney was Director of Operations for Telrepco
Inc.,  which  manufactured  and  repaired   telephone   equipment  and  personal
computers,  and from 1983 to March 1989, Mr. Mahoney was General  Manager of the
Repair Division of TIE Communications,  Inc., which manufactured and distributed
telephone equipment.

       Mr. Stein became Vice  President - Sales of the Company in February  1994
after becoming employed by the Company in December 1993 following  completion of
the Company's  transaction  with Muelhens Inc. Prior thereto,  Mr. Stein was the
President of  Contemporary  Sales,  Inc., a company he founded in 1973 and which
served as a manufacturer's sales representative in the retail field.

       During  the  fiscal  year ended June 30,  1995,  the  Company's  Board of
Directors  held seven  meetings.  All directors were present for at least 75% of
such meetings. The Company does not have a standing Compensation,  Nominating or
Audit Committee.

Compliance with Section 16(a) of the Exchange Act

       Section  16(a)  of the  Securities  Exchange  Act of  1934,  as  amended,
requires the Company's officers, directors and persons who beneficially own more
than ten percent of the Company's common stock to file reports of ownership and

                                                   16

<PAGE>
changes in ownership with the Securities and Exchange Commission and the Pacific
Stock Exchange. These reporting persons also are required to furnish the Company
with copies of all Section 16(a) forms they file.  To the  Company's  knowledge,
based  solely on its  review of the  copies of such  forms  furnished  to it and
representations  that no other reports were required,  the Company believes that
all Section 16(a)  reporting  requirements  were complied with during the fiscal
year ended June 30, 1995.

Executive Compensation

       The following table sets forth  information  concerning  compensation for
fiscal 1995,  1994 and 1993 earned by or paid to the Company's  chief  executive
officer and each other executive officer whose compensation exceeded $100,000 in
fiscal 1995:
<TABLE>
<CAPTION>

- -----------------------------------------------------------------------------------------------------------------------------------
                                                       SUMMARY COMPENSATION TABLE
- -----------------------------------------------------------------------------------------------------------------------------------
                                                                                              Annual Compensation
                                                                    ---------------------------------------------------------------
                 <S>                                       <C>          <C>                  <C>                   <C>
                                                                                                                Other Annual    
                     Name and                                         Salary                Bonus              Compensation(1)
               Principal Occupation                       Year          ($)                  ($)                     ($)
- -----------------------------------------------------------------------------------------------------------------------------------
                                                          1995        227,950                -0-                   1,922(2)
Richard Barrie,                                           1994        198,125               16,000                66,500(2)
       President and chief executive officer              1993        150,000                -0-                   8,000(2)
- -----------------------------------------------------------------------------------------------------------------------------------
                                                          1995        92,250                 -0-                  17,500(3)
Ronald Stein,                                             1994        48,750                 -0-                     -0-
  Vice President-Sales                                    1993          N/A                  N/A                     N/A
- -----------------------------------------------------------------------------------------------------------------------------------

<FN>

(1)    The named executives  routinely  receive other benefits from the Company,
       the aggregate  amounts of which during the years indicated did not exceed
       10% of the salary and bonus set forth above.

(2)    For fiscal 1995 represents the imputed  economic benefit to the executive
       of premiums paid for a "split dollar"  insurance policy (discussed below)
       insuring  the life of the named  executive  officer.  For fiscal 1994 and
       1993,  represents  reimbursement for premiums paid on insurance  policies
       insuring the life of the named  executive  officer for the benefit of his
       family.  In fiscal  1994 also  represents  reimbursement  of  $58,500  in
       personal relocation expenses.

(3)    Represents reimbursement for personal relocation expenses.
</FN>
</TABLE>
Compensation Arrangements

       Chief Executive  Officer.  Through September 30, 1993, Richard Barrie was
employed pursuant to an employment  agreement  providing for an annual salary of
$150,000 and  reimbursement (up to $8,000 per year) for the cost of private life
insurance  maintained  by Mr.  Barrie for the benefit of his  family.  Effective
October 1, 1993, the Company entered into a new three-year  employment agreement
with Mr. Barrie  pursuant to which he would be paid an annual salary of $180,000
per year, which increased to $225,000 effective December 15, 1994, following the
Company's  completion of its transaction with Muelhens Inc., with annual cost of
living  adjustments  based upon the consumer  price index.  The  agreement  also
provided for the Company to reimburse Mr. Barrie (up to $8,000 per year) for the
cost of private life insurance through June 30, 1994. In August 1994 the Company
purchased for Mr. Barrie a $6,000,000  "split  dollar"  insurance  policy on his
life, which provides a $3,000,000 "key man" death benefit payable to the Company
and a $3,000,000 death benefit payable to Mr. Barrie's designated beneficiaries.
The policy is structured to provide for repayment of the premiums to the Company
upon the  earlier  of Mr.  Barrie's  death or  attainment  of the age of 67. The
policy is further  structured  to provide Mr.  Barrie with a retirement  benefit
from the cash surrender value of the policy.

       Directors.  In  September  1993,  the Company  adopted  the  Non-Employee
Director  Compensation  Plan for all  directors  not  employed  by the  Company.
Pursuant  to this  Compensation  Plan,  on  September  20,  1993,  the four then
non-employee directors of the Company -- Mrs. Barrie and Messrs. McEnany, Nadler
and Pochna -- were each granted  ten-year  options to purchase  15,000 shares of
common stock at an exercise  price of $2.25 per share (the closing  price of the
common stock on the Pacific Stock Exchange on the date of the grant). All of the
options are currently  exercisable.  On February 2, 1994, this Compensation Plan
was amended to provide for payment of $500 to each non-

                                                   17

<PAGE>



employee  director of the Company for each meeting  attended.  In February 1995,
Patrick  McEnany  resigned from the Company's  Board of Directors  after several
years of service.  In consideration of his services to the Company,  on February
21, 1995,  the Company was  authorized  to amend the terms of the  September 20,
1993 Stock Option  Agreement with Mr.  McEnany  pursuant to which he was granted
ten-year  options to purchase 15,000 shares of common stock at an exercise price
of $2.25 per share. Under the terms of the original agreement, such options were
to expire  immediately  upon his  resignation  (with respect to options not then
exercisable)   or  thirty  days   thereafter   (with  respect  to  options  then
exercisable).  The amendment  modified such terms to eliminate  such  expiration
provision.  In  addition,  the  Company  was  authorized  to grant  "piggy-back"
registration  rights with  respect to the shares of common stock  issuable  upon
exercise of such  options,  such that these  shares would be included in certain
future registration  statements filed by the Company under the Securities Act of
1933 without cost to Mr.  McEnany.  On April 17, 1995, the exercise price of the
options held by Mrs.  Barrie and Messrs.  Nadler and Pochna (Mr.  McEnany having
resigned from the Board of Directors by that time) were reduced to $1.4375,  the
closing  price of the Company's  common stock on the Pacific  Stock  Exchange on
such date.

       Option  Grants to  Executive  Officers.  On April 17,  1995,  the Company
granted  ten-year  options  to  purchase  25,000  shares of  common  stock at an
exercise  price of $1.4375 (the closing price of the common stock on the Pacific
Stock  Exchange  on the date of grant) to Mr.  Barrie  and  similar  options  to
purchase  10,000  shares of common stock to each of Messrs.  Buvel,  Mahoney and
Stein, Vice Presidents of the Company.  Such options were to become  exercisable
as to 50% on each of the first and second  anniversary  dates of the  grant.  In
October  1995,  all  of  these  options  were  voluntarily  relinquished  by the
grantees.

Certain Relationships and Related Transactions.

     Stephen T. Meadow, a nominee for director, owns $39,000 principal amount of
Notes.  Mr.  Meadow has advised  the  Company  that he intends to consent to the
Asset Sale and to participate in the Proposed Exchange. If the Proposed Exchange
is completed,  and if Mr. Meadow participates  therein, Mr. Meadow would receive
four Preferred Shares and 4,600 Common Shares. Mr. Meadow has been retained as a
consultant  to the  Company.  For  his  services,  Mr.  Meadow  will  receive  a
consulting  fee  calculated  at the rate of $75 per hour to a maximum  amount of
$2,000 per month.  In all events,  Mr. Meadow will receive a minimum  consulting
fee of $1,500 per month.

       Charles D. Snead,  Jr., a nominee for director,  has been retained by the
Company as a consultant in connection  with the Asset Sale.  Upon  completion of
the Asset Sale the Company  proposes to retain Mr.  Snead as its  President  and
Chief Executive Officer. For his services to the Company, Mr. Snead will receive
consulting  fees  calculated at the rate of $75 per hour to a maximum  amount of
$5,000 per month. In all events, Mr. Snead will receive a minimum consulting fee
of $3,000 per month.

       If elected to be directors of the Company at the meeting, each of Messrs.
Meadow and Snead will  receive  options to  purchase  10,000 and 30,000  shares,
respectively,  of the Company's  common stock having an exercise  price equal to
the market price of the  Company's  common  stock on the date of issuance.  Such
options will be immediately exercisable.


                        SELECTION OF INDEPENDENT AUDITORS

               The Board of Directors  has selected the  independent  accounting
firm of Arthur  Andersen  LLP as the auditors of the Company for the fiscal year
ending June 30, 1996. A  representative  of Arthur Andersen LLP, the auditors of
the Company for the fiscal year ended June 30,  1995,  is expected to be present
at the meeting. The representative will have the opportunity to make a statement
and will be available to respond to appropriate questions from stockholders.


                           1996 STOCKHOLDER PROPOSALS

               In order for stockholder proposals for the 1996 Annual Meeting of
Stockholders to be eligible for inclusion in the Company's Proxy Statement, they
must be received by the Company at its principal  office in Orange,  Connecticut
not later than August 30, 1996.



                                                   18

<PAGE>


                                  OTHER MATTERS

               The Board of Directors knows of no matter which will be presented
for  consideration  at the meeting  other than the  matters  referred to in this
Proxy Statement. Should any other matter properly come before the meeting, it is
the intention of the persons named in the accompanying  proxy to vote such proxy
in accordance with their best judgment.


                             SOLICITATION OF PROXIES

               Solicitation  of proxies is being made by the Company through the
mail, in person and by telecommunications. The cost thereof will be borne by the
Company.  The  Company  will  also  request  brokers,  dealers,  banks and their
nominees to solicit  proxies from their  clients,  where  appropriate,  and will
reimburse them for reasonable expenses related thereto.


                             Lynn Barrie, Secretary


Orange, Connecticut
April 22, 1996

                                                   19

<PAGE>
                                                                 


                               ARTHUR ANDERSEN LLP



                    REPORT OF INDEPENDENT PUBLIC ACCOUNTANTS


To Richard Barrie Fragrances, Inc.:

We have audited the  accompanying  balance sheets of Richard Barrie  Fragrances,
Inc.  (a  Nevada  corporation)  as of June 30,  1995 and 1994,  and the  related
statements of operations,  stockholders' equity and cash flows for the two years
then ended.  These financial  statements are the responsibility of the Company's
management.  Our  responsibility  is to express  an  opinion on these  financial
statements based on our audits.

We  conducted  our  audits  in  accordance  with  generally   accepted  auditing
standards.  Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material
misstatement.  An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements.  An audit also includes
assessing the  accounting  principles  used and  significant  estimates  made by
management,  as well as evaluating the overall financial statement presentation.
We believe that our audits provide a reasonable basis for our opinion.

In our opinion,  the financial  statements  referred to above present fairly, in
all material respects, the financial position of Richard Barrie Fragrances, Inc.
as of June 30,  1995 and 1994,  and the results of its  operations  and its cash
flows  for the two  years  then  ended in  conformity  with  generally  accepted
accounting principles.

The  accompanying  financial  statements  have been  prepared  assuming that the
Company  will  continue  as a  going  concern.  As  described  in  Note 3 to the
financial  statements,  the Company  failed to make the July 15,  1995  interest
payment of $257,887 due on Convertible  Notes Payable in the principal amount of
$5,157,750,  which  principal  is due  January 16,  1996.  If the Company is not
successful in implementing  its plans to either (i) restructure  this debt, (ii)
induce  conversion of these  convertible  notes or (iii) obtain  financing  from
other third parties, the Company would need to consider a voluntary filing under
Chapter 11 of the United States Bankruptcy Code. These factors raise substantial
doubt about the Company's ability to continue as a going concern.  The financial
statements  do not include any  adjustments  relating to the  recoverability  or
classification  of asset carrying  amounts or the amount and  classification  of
liabilities  that might  result  should the  Company be unable to  continue as a
going concern.



                                                   /s/ Arthur Andersen LLP

Melville, New York
September 21, 1995



<PAGE>
                                                     


               REPORT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS



To the Board of Directors and
Shareholders of Parlux Fragrances, Inc.

In our  opinion,  the  consolidated  financial  statements  listed  in the index
referred to under Item  14(a)(1)  and (2) on page 19 and  appearing  on page F-1
present  fairly,  in all material  respects,  the  financial  position of Parlux
Fragrances,  Inc.  and its  subsidiaries  at March 31,  1995 and  1994,  and the
results of their  operations and their cash flows for each of the three years in
the  period  ended  March  31,  1995,  in  conformity  with  generally  accepted
accounting principles.  These financial statements are the responsibility of the
Company's  management;  our  responsibility  is to  express  an opinion on these
financial  statements  based on our  audits.  We  conducted  our audits of these
statements  in accordance  with  generally  accepted  auditing  standards  which
require that we plan and perform the audit to obtain reasonable  assurance about
whether the financial  statements  are free of material  misstatement.  An audit
includes  examining,  on a test  basis,  evidence  supporting  the  amounts  and
disclosures in the financial  statements,  assessing the  accounting  principles
used and  significant  estimates made by management,  and evaluating the overall
financial  statement  presentation.   We  believe  that  our  audits  provide  a
reasonable basis for the opinion expressed above.




/s/ Price Waterhouse LLP
PRICE WATERHOUSE LLP
Miami, Florida
June 16, 1995




<PAGE>
                     RICHARD BARRIE FRAGRANCES, INC. - PROXY
                  Solicited on Behalf of the Board Of Directors

PROXY

         The undersigned  hereby appoints LYNN BARRIE,  RICHARD BARRIE and PETER
POCHNA (each with full power to act without the others and with power to appoint
his or her substitute) as the undersigned's proxies to vote all shares of Common
Stock of the  undersigned  in RICHARD BARRIE  FRAGRANCES,  INC.  ("Company"),  a
Nevada  corporation,  which the  undersigned  would be  entitled  to vote at the
Special Meeting of  Stockholders of the Company to be held on Friday,  May 31,
1996, at 10:00 a.m. and at any and all adjournments thereof as follows:

1.       PROPOSAL TO APPROVAL THE SALE OF VIRTUALLY ALL OF THE COMPANY'S ASSETS
         TO PARLUX FRAGRANCES, INC.:

        |_|  FOR           |_|  AGAINST                |_|  ABSTAIN

2.       PROPOSAL TO CHANGE THE COMPANY'S NAME TO FBR CAPITAL CORPORATION:

        |_|  FOR           |_|  AGAINST                |_|  ABSTAIN

3.       ELECTION OF DIRECTORS 
  
         FOR all nominees listed below        WITHHOLD AUTHORITY
        (except as marked to the contrary     to vote for all nominees 
         below |_|                            listed below |_|
    
                         STEPHEN T. MEADOW, WAYNE STERN

                 (continued, and to be signed, on reverse side)




4.       In their discretion upon such other business as may properly come 
         before the meeting and any and all adjournments thereof.

         The shares of Common Stock  represented  by this proxy will be voted in
         accordance  with the  foregoing  Instructions.  In the  absence  of any
         instructions,  such shares will be voted FOR the  proposals  in Items 1
         and 2 and FOR the election of the nominees listed in Item 3.

         The undersigned  hereby  acknowledges  receipt of the Notice of Special
         Meeting  of  Stockholders  to be held on May 31,  1996 and the Proxy
         Statement furnished therewith.

         The undersigned hereby revokes any proxy to vote shares of Common Stock
         of the Company heretofore given by the undersigned.




                                      Date _____________________________, 1996


                                      ----------------------------------------
                                       Signature


                                      Please date, sign exactly as name appears
                                      on this proxy, and promptly return in the
                                      enclosed envelope. When signing as
                                      guardian, executor, administrator,
                                      attorney, trustee, custodian, or in any
                                      other similar capacity, please give full
                                      title. If a corporation, sign in full
                                      corporate name by president or other
                                      authorized officer, giving title, and
                                      affix corporate seal. If a partnership,
                                      sign in partnership name by authorized
                                      person. In the case of joint ownership,
                                      each joint owner must sign.




<PAGE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission